<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=Estrone_glucuronide</id>
	<title>Estrone glucuronide - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=Estrone_glucuronide"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Estrone_glucuronide&amp;action=history"/>
	<updated>2026-04-12T09:10:22Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=Estrone_glucuronide&amp;diff=49858&amp;oldid=prev</id>
		<title>WikiSysop: 1版 をインポートしました</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Estrone_glucuronide&amp;diff=49858&amp;oldid=prev"/>
		<updated>2025-03-18T10:31:23Z</updated>

		<summary type="html">&lt;p&gt;1版 をインポートしました&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ja&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← 古い版&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;2025年3月18日 (火) 19:31時点における版&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;ja&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(相違点なし)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key wiki-mw_:diff:1.41:old-49857:rev-49858 --&gt;
&lt;/table&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=Estrone_glucuronide&amp;diff=49857&amp;oldid=prev</id>
		<title>bsd&gt;Arthurfragoso: dark mode fix</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Estrone_glucuronide&amp;diff=49857&amp;oldid=prev"/>
		<updated>2025-01-09T16:31:49Z</updated>

		<summary type="html">&lt;p&gt;dark mode fix&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Use dmy dates|date=August 2018}}&lt;br /&gt;
{{Chembox&lt;br /&gt;
&amp;lt;!-- Images --&amp;gt;&lt;br /&gt;
| ImageFile = Estrone 3-glucuronide.svg&lt;br /&gt;
| ImageClass = skin-invert&lt;br /&gt;
| ImageSize = 225px&lt;br /&gt;
| ImageAlt =&lt;br /&gt;
&amp;lt;!-- Names --&amp;gt;&lt;br /&gt;
| IUPACName = 17-Oxoestra-1,3,5(10)-trien-3-yl β-&amp;lt;small&amp;gt;D&amp;lt;/small&amp;gt;-glucopyranosiduronic acid&lt;br /&gt;
| SystematicName = (2&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,3&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,4&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,5&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,6&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-3,4,5-Trihydroxy-6-&amp;lt;nowiki/&amp;gt;{[(3a&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,3b&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,9b&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,11a&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-11a-methyl-1-oxo-2,3,3a,3b,4,5,9b,10,11,11a-decahydro-1&amp;#039;&amp;#039;H&amp;#039;&amp;#039;-cyclopenta[&amp;#039;&amp;#039;a&amp;#039;&amp;#039;]phenanthren-7-yl]oxy}oxane-2-carboxylic acid&lt;br /&gt;
| OtherNames = Estrone 3-glucuronide; Estrone 3-&amp;lt;small&amp;gt;D&amp;lt;/small&amp;gt;-glucuronide; Estra-1,3,5(10)-triene-3-ol-17-one 3-&amp;lt;small&amp;gt;D&amp;lt;/small&amp;gt;-glucuronoside&lt;br /&gt;
&amp;lt;!-- Sections --&amp;gt;&lt;br /&gt;
| Section1 = {{Chembox Identifiers&lt;br /&gt;
| CASNo = 2479-90-5&lt;br /&gt;
| ChEBI = &lt;br /&gt;
| ChEMBL = 1232444&lt;br /&gt;
| ChemSpiderID = 103124&lt;br /&gt;
| KEGG = C11133&lt;br /&gt;
| PubChem = 115255&lt;br /&gt;
| SMILES = C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O&lt;br /&gt;
| StdInChI = 1S/C24H30O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-16,18-21,23,26-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,18+,19+,20-,21+,23-,24+/m1/s1&lt;br /&gt;
| StdInChIKey = FJAZVHYPASAQKM-JBAURARKSA-N&lt;br /&gt;
| UNII = 933Q277TO2&lt;br /&gt;
  }}&lt;br /&gt;
| Section2 = {{Chembox Properties&lt;br /&gt;
| C=24 | H=30 | O=8&lt;br /&gt;
| Appearance = &lt;br /&gt;
| Density = &lt;br /&gt;
| MeltingPt = &lt;br /&gt;
| BoilingPt = &lt;br /&gt;
| Solubility = &lt;br /&gt;
  }}&lt;br /&gt;
| Section3 = {{Chembox Hazards&lt;br /&gt;
| MainHazards =&lt;br /&gt;
| FlashPt =&lt;br /&gt;
| AutoignitionPt =&lt;br /&gt;
  }}&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Estrone glucuronide&amp;#039;&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;&amp;#039;estrone-3-&amp;lt;small&amp;gt;D&amp;lt;/small&amp;gt;-glucuronide&amp;#039;&amp;#039;&amp;#039;, is a [[conjugation (biochemistry)|conjugated]] [[metabolite]] of [[estrone]].&amp;lt;ref name=&amp;quot;HMDB&amp;quot;&amp;gt;{{Cite web|url=http://www.hmdb.ca/metabolites/HMDB04483|title = Human Metabolome Database: Showing metabocard for Estrone glucuronide (HMDB0004483)}}&amp;lt;/ref&amp;gt; It is formed from estrone in the [[liver]] by [[UDP-glucuronyltransferase]] via attachment of [[glucuronic acid]] and is eventually [[excretion|excreted]] in the [[urine]] by the [[kidney]]s.&amp;lt;ref name=&amp;quot;HMDB&amp;quot; /&amp;gt; It has much higher [[water solubility]] than does estrone.&amp;lt;ref name=&amp;quot;HMDB&amp;quot; /&amp;gt; Glucuronides are the most abundant estrogen conjugates and estrone glucuronide is the dominant metabolite of estradiol.&amp;lt;ref name=&amp;quot;HMDB&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
When [[exogenous]] estradiol is administered [[oral administration|orally]], it is subject to extensive [[first-pass metabolism]] (95%) in the [[intestine]]s and [[liver]].&amp;lt;ref name=&amp;quot;OettelSchillinger2012&amp;quot;&amp;gt;{{cite book| first1 = Michael | last1 = Oettel | first2 = Ekkehard | last2 = Schillinger | name-list-style = vanc | title = Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen|url=https://books.google.com/books?id=wBvyCAAAQBAJ&amp;amp;pg=PA268|date=6 December 2012|publisher=Springer Science &amp;amp; Business Media|isbn=978-3-642-60107-1|pages=268–}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;LauritzenStudd2005&amp;quot;&amp;gt;{{cite book|first1 = Christian | last1 =  Lauritzen | first2 = John W. W. | last2 = Studd | name-list-style = vanc |title=Current Management of the Menopause|url=https://books.google.com/books?id=WD7S7677xUUC&amp;amp;pg=PA364|date=22 June 2005|publisher=CRC Press|isbn=978-0-203-48612-2|pages=364–}}&amp;lt;/ref&amp;gt; A single administered dose of estradiol is [[absorption (pharmacokinetics)|absorbed]] 15% as [[estrone]], 25% as [[estrone sulfate]], 25% as [[estradiol glucuronide]], and 25% as estrone glucuronide.&amp;lt;ref name=&amp;quot;OettelSchillinger2012&amp;quot; /&amp;gt; Formation of [[estrogen]] glucuronide conjugates is particularly important with oral estradiol as the percentage of estrogen glucuronide conjugates in circulation is much higher with oral ingestion than with [[parenteral]] estradiol.&amp;lt;ref name=&amp;quot;OettelSchillinger2012&amp;quot; /&amp;gt; Estrone glucuronide can be reconverted back into estradiol, and a large circulating pool of estrogen glucuronide and sulfate conjugates serves as a long-lasting reservoir of estradiol that effectively extends its [[terminal half-life]] of oral estradiol.&amp;lt;ref name=&amp;quot;OettelSchillinger2012&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;LauritzenStudd2005&amp;quot; /&amp;gt; In demonstration of the importance of first-pass metabolism and the estrogen conjugate reservoir in the [[pharmacokinetics]] of estradiol,&amp;lt;ref name=&amp;quot;OettelSchillinger2012&amp;quot; /&amp;gt; the terminal half-life of oral estradiol is 13 to 20 hours&amp;lt;ref name=&amp;quot;StanczykArcher2013&amp;quot;&amp;gt;{{cite journal | vauthors = Stanczyk FZ, Archer DF, Bhavnani BR | title = Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment | journal = Contraception | volume = 87 | issue = 6 | pages = 706–27 | date = June 2013 | pmid = 23375353 | doi = 10.1016/j.contraception.2012.12.011 }}&amp;lt;/ref&amp;gt; whereas with [[intravenous injection]] its terminal half-life is only about 1 to 2 hours.&amp;lt;ref name=&amp;quot;pmid7169965&amp;quot;&amp;gt;{{cite journal | vauthors = Düsterberg B, Nishino Y | title = Pharmacokinetic and pharmacological features of oestradiol valerate | journal = Maturitas | volume = 4 | issue = 4 | pages = 315–24 | date = December 1982 | pmid = 7169965 | doi =  10.1016/0378-5122(82)90064-0}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{Affinities and estrogenic potencies of estrogen esters and ethers at the estrogen receptors}}&lt;br /&gt;
&lt;br /&gt;
{{Estradiol metabolism|align=right}}&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
* [[Catechol estrogen]]&lt;br /&gt;
* [[Estradiol sulfate]]&lt;br /&gt;
* [[Estriol glucuronide]]&lt;br /&gt;
* [[Estriol sulfate]]&lt;br /&gt;
* [[Estrogen conjugate]]&lt;br /&gt;
* [[Lipoidal estrogen]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
== External links ==&lt;br /&gt;
* [http://www.hmdb.ca/metabolites/HMDB04483 Metabocard of Estrone Glucuronide – Human Metabolome Database]&lt;br /&gt;
&lt;br /&gt;
{{Steroid hormones}}&lt;br /&gt;
{{Estrogen receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Estranes]]&lt;br /&gt;
[[Category:Estrogens]]&lt;br /&gt;
[[Category:Estrone esters]]&lt;br /&gt;
[[Category:Glucuronide esters]]&lt;br /&gt;
[[Category:Human metabolites]]&lt;/div&gt;</summary>
		<author><name>bsd&gt;Arthurfragoso</name></author>
	</entry>
</feed>